LakeShore Biopharma Co., Ltd (LSB) — Defensive Interval Ratio
LakeShore Biopharma Co., Ltd (LSB) has a Defensive Interval Ratio of 222 days as of June 2025. Defensive assets of $501.79 Million (cash $-, short-term investments $-, receivables $501.79 Million) cover 222 days of daily cash needs of $2.26 Million/day. Check LakeShore Biopharma Co., Ltd (LSB) tangible net worth to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
LakeShore Biopharma Co., Ltd Defensive Interval Ratio (2021–2025)
This chart shows how LakeShore Biopharma Co., Ltd's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2025, the ratio stands at 222 days, meaning defensive assets of $501.79 Million can fund 222 days of operations without new revenue. Also explore LakeShore Biopharma Co., Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for LakeShore Biopharma Co., Ltd (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for LakeShore Biopharma Co., Ltd from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of LakeShore Biopharma Co., Ltd.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 222 days | $501.79 Million | $2.26 Million/day | $- | $- | ▲ +20 days |
| 2024 | 202 days | $444.16 Million | $2.20 Million/day | $- | $- | ▼ -57 days |
| 2023 | 259 days | $468.20 Million | $1.80 Million/day | $- | $- | ▼ -789349 days |
| 2022 | 789608 days | $308.56 Million | $390.77/day | $- | $- | ▲ +789381 days |
| 2021 | 227 days | $214.50 Million | $945.32K/day | $- | $- | — |